Skip to main content
Premium Trial:

Request an Annual Quote

Heiner Dreismann

Heiner Dreismann, former CEO of Roche Molecular Systems, has joined the executive advisory board of MyDx, maker of a multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers. Under Dreismann's leadership, Roche expanded its portfolio of molecular tests and instruments. Prior to his appointment as CEO of Roche Molecular, Dreismann held other senior positions within Roche, including as head of global business development for Roche Diagnostics, European business unit manager for PCR, head of its business unit for microbiology, R&D positions in microbiology and infectious diseases, and head of manufacturing for infectious disease diagnostics.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.